Teva Selling Northern Israeli Plant to FIMI Fund for $45 Million

The sale of the Kiryat Shmona facility was made possible by a collective labor agreement between Teva and the 170 plant workers

comments Print
Teva Pharmaceutical Industries is expected to announce the sale of its Migada plant in Kiryat Shmona to FIMI Opportunity Funds for $45 million.